Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
1.030
+0.030 (3.00%)
At close: Jan 29, 2026, 4:00 PM EST
1.040
+0.010 (0.97%)
After-hours: Jan 29, 2026, 6:00 PM EST
Humacyte Market Cap
Humacyte has a market cap or net worth of $198.79 million as of January 29, 2026. Its market cap has decreased by -62.50% in one year.
Market Cap
198.79M
Enterprise Value
230.27M
1-Year Change
-62.50%
Ranking
Category
Stock Price
$1.03
Market Cap Chart
Since December 1, 2020, Humacyte's market cap has increased from $124.31M to $198.79M, an increase of 59.91%. That is a compound annual growth rate of 9.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 198.79M | 7.24% |
| Dec 31, 2025 | 185.37M | -71.47% |
| Dec 31, 2024 | 649.78M | 120.90% |
| Dec 29, 2023 | 294.15M | 35.19% |
| Dec 30, 2022 | 217.58M | -70.86% |
| Dec 31, 2021 | 746.77M | 471.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Surrozen | 195.81M |
| Sagimet Biosciences | 194.80M |
| Context Therapeutics | 193.41M |
| Cartesian Therapeutics | 190.71M |
| Minerva Neurosciences | 189.97M |
| Opus Genetics | 188.96M |
| Kalaris Therapeutics | 188.89M |
| Camp4 Therapeutics | 188.32M |